Geng-Hao Bai
Meng-Chen Tsai
Sheng-Chieh Lin
Yi-Hsiang Hsu
Shih-Yen Chen
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
- 2Department of General Medicine, Taipei Medical University Hospital, Taipei, Taiwan
- 3Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 4Department of Pediatrics, Division of Allergy, Asthma and Immunology, Shuang Ho Hospital, New Taipei, Taiwan
- 5Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States
- 6Broad Institute of MIT and Harvard, Cambridge, MA, United States
- 7Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Shuang Ho Hospital, New Taipei, Taiwan
- 8TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei, Taiwan
A corrigendum on
Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
by Bai, G.-H., Tsai, M.-C., Lin, S.-C., Hsu, Y.-H., and Chen, S.-Y. (2023). Front. Microbiol. 14:1212582. doi: 10.3389/fmicb.2023.1212582
In the published article, there was an error in the Funding statement. The statement previously read “The study was supported by grants from MOST 108-2314- B-038−097 and MOST 111-2622-E-038-001, Taiwan.” The correct Funding statement appears below.
Funding
The study was supported by grants from NSTC 112-2622-E-038-004, Taiwan.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: norovirus, microbiota, probiotics, norovirus vaccine, human intestinal enteroid
Citation: Bai G-H, Tsai M-C, Lin S-C, Hsu Y-H and Chen S-Y (2023) Corrigendum: Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. Front. Microbiol. 14:1324539. doi: 10.3389/fmicb.2023.1324539
Received: 19 October 2023; Accepted: 15 November 2023;
Published: 01 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Bai, Tsai, Lin, Hsu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shih-Yen Chen, MTgxNTlAcy50bXUuZWR1LnR3
†These authors have contributed equally to this work